The Appleby team was led by Partner Chris Cheng and assisted by Partner Vincent Chan and Legal Executive Connie Wu.

Mega Genomics is a leading genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services.

Mega Genomics intends to use the net proceeds from the Global Offering for promotion, research and development of its services and products, expansion of its testing capability and capacity, working capital and other general corporate purposes.

Our Hong Kong Capital Markets team is highly regarded for their extensive expertise in supporting offshore companies with IPOs, introductions, placements and listings of both equity and debt securities on the Hong Kong, US, Singapore and many other internationally recognised stock exchanges.

Share
Twitter LinkedIn Email Save as PDF
More Deals
31 May 2023 | Deals

Appleby advises Pegasus Digital Mobility Acquisition Corp. on its entry into a business combination with the Schmid Group

Appleby is advising NYSE-listed Pegasus Digital Mobility Acquisition Corp. (“Pegasus”), a specia...

23 May 2023 | Deals

Appleby advises Black Spade Acquisition Co on its proposed merger with VinFast

This will be the largest US listing by a company from Vietnam.

29 Mar 2023 | Deals

Appleby’s Hong Kong office advises Seacon Shipping on its HKD386.8 million listing on the main board of the Hong Kong Stock Exchange

We are pleased to assist Seacon Shipping which ranked first among ship management service providers ...

1 Nov 2022 | Deals

Appleby advises Endurance Acquisition Corp. on its de-SPAC business combination with SatixFy Communications Ltd.

Appleby is pleased to have acted as Cayman Islands legal counsel to Endurance Acquisition Corp. (NAS...

5 Oct 2022 | Deals

Appleby advises Silver Crest Acquisition Corporation on successful completion of US$1.4 billion de-spac with Tims China

Appleby is pleased to have acted as Cayman Islands legal counsel to Silver Crest Acquisition Corpora...

7 Sep 2022 | Deals

Appleby’s Hong Kong office advises Graphex Group limited on its USD 11.7 million listing on the NYSE American LLC stock exchange market

On 26 August 2022, Graphex Group’s underwriters have exercised their over-allotment option to purc...

17 Aug 2022 | Deals

Appleby’s Hong Kong office advises WEIli Holdings Limited on its HKD126 million listing on the Main Board of the Hong Kong Stock Exchange

WEIli is a PRC-based cigarette packaging paper manufacturer with research and development capabiliti...

20 May 2022 | Deals

Appleby advises Artisan Acquisition Corp. on its de-SPAC Business Combination with Prenetics Group Limited

Appleby is pleased to have acted as Cayman Islands legal counsel to Artisan Acquisition Corp. on its...